Observed Changes in Natural Killer and T cell Phenotypes with Evaluation of Immune Outcome in a Longitudinal Cohort Following Sofosbuvir-Based Therapy for Chronic Hepatitis C Infection

DOI: 10.1093/ofid/ofz223

Keywords: antiviral therapy, DAA therapy, HCV, liver disease, Sofosbuvir

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text